Nurix Therapeutics, Inc. H-1B wage filings
Brisbane, CA. Filings decided July 2025 to June 2026.
Nurix Therapeutics, Inc. filed 10 wage applications for H-1B and similar visas from July 2025 to June 2026. The median wage it offered was $118,597, 5.7% above the government's prevailing wage for the same jobs.
- Filings
- 10
- Positions covered
- 9
- Certified
- 90.0%
- Job titles
- 9
- Worksite cities
- 2
- Filings since FY2020
- 62
- Median offer change since FY2021
- +27%
Offered wage since 2020
Nurix Therapeutics, Inc.'s median H-1B wage offer rose 27%, from $110,000 in fiscal 2021 to $139,855 in fiscal 2026 so far. In fiscal 2026 it was 6.6% above the prevailing wage. Its busiest full year was fiscal 2025, with 18 filings.
Middle half of offered wagesMedian offered wageMedian prevailing wageFilings per year
Fiscal years run October to September. Fiscal 2026 is still running: these figures cover October 2025 to June 2026.
Nurix Therapeutics, Inc. by fiscal year
| Fiscal year | Filings | Median offered | vs year before | Median prevailing | vs prevailing |
|---|---|---|---|---|---|
| 2026 (Oct to Jun) | 6 | $139,855 | −0.1% | $127,276 | +6.6% |
| 2025 | 18 | $140,000 | −6.7% | $137,072 | +2.1% |
| 2024 | 9 | $150,000 | +50.0% | $109,741 | +4.1% |
| 2023 | 9 | $100,000 | −22.5% | $92,768 | +7.8% |
| 2022 | 12 | $129,000 | +17.3% | $111,072 | +9.7% |
| 2021 | 6 | $110,000 | n/a | $80,933 | at the minimum |
| 2020 | 2 | n/a | n/a | n/a | n/a |
Offered wage by job title
Middle half of offered wagesMedian offered wageMedian prevailing wage
| Job title | Filings | Median offered | Offered range and prevailing wage | vs prevailing |
|---|---|---|---|---|
| Medicinal Chemistry Contractor | 2 | $87,360 | +11.6% | |
| Associate Director, Clinical Data Management | 1 | $225,000 | +68.0% | |
| Research Associate II, Preclinical Pharmacology | 1 | $113,000 | +0.4% | |
| Research Associate III, Discovery Biology | 1 | $118,597 | +7.4% | |
| Scientist I, Preclinical Pharmacology | 1 | $129,709 | at the minimum | |
| Scientist I, Proteomics | 1 | $165,000 | +32.2% | |
| Scientist II, Cell Screening and Pharmacology | 1 | $150,000 | +5.7% | |
| Scientist II “ Cell Biology | 1 | $115,000 | +1.9% | |
| Senior Research Associate | 1 | $110,000 | +0.2% | |
No job title on this page matches. Only the most-filed titles are listed.
Where the jobs are
| Worksite | Filings | Median offered |
|---|---|---|
| Brisbane, CA | 5 | $150,000 |
| San Francisco, CA | 5 | $111,500 |
By visa type: 9 H-1B, 1 E-3 (Australia). By outcome: 8 certified, 1 certified and later withdrawn, 1 withdrawn before a decision.
Filings by quarter
Across all employers, filings bunch up in the first half of each year around the annual H-1B lottery, so compare a quarter with the same quarter a year earlier, not with the one before it.
Seniority of the jobs filed
The government assigns each job one of four wage levels. A higher level means a higher legal minimum.
What these numbers are
- They are wages Nurix Therapeutics, Inc. attested to on Labor Condition Applications (Form ETA-9035), not paychecks. Bonuses and stock are not included.
- A filing is not a visa or a hire. One filing can cover several positions, and some are later withdrawn. Wage figures use certified filings only.
- The prevailing wage is the minimum the employer must pay for that job in that area, set from government wage surveys.
Source: U.S. Department of Labor, OFLC disclosure data. How we clean and count it.